Cytokinetics Inc (CYTK)

Receivables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	18,474	3,219	3,134	3,752	7,530	7,815	9,952	98,053	94,588	148,231	151,153	65,028	70,428	21,550	57,801	58,551	55,828	54,318	18,685	22,229
Receivables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $18,474K ÷ $—K
= —

The receivables turnover ratio for Cytokinetics Inc is not available for the periods specified in the provided data. The receivables turnover ratio indicates how efficiently a company is managing its accounts receivable by measuring the number of times a company collects its average accounts receivable balance during a specific period.

As the receivables turnover ratio information is not provided, we are unable to assess how quickly Cytokinetics Inc is collecting payments from its customers or how effectively it is managing its credit policies. It is important to note that a high receivables turnover ratio generally indicates efficient management of receivables, while a low ratio may suggest potential issues such as ineffective collection processes or credit policies.

To gain a better understanding of Cytokinetics Inc's receivables turnover performance, it would be beneficial to obtain data for the relevant periods and calculate this ratio to assess the company's efficiency in collecting outstanding payments from its customers over time.